Profiel
Jim Scully served as the Chief Executive & Accounting Officer at Seneca Biopharma, Inc. from 2018 to 2019.
He holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Jim Scully
| Bedrijven | Functie | Einde |
|---|---|---|
| PALISADE BIO, INC. | Algemeen Directeur | 01-01-2019 |
Opleiding van Jim Scully
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
